Document Detail


Survivin in Adrenocortical Tumors - Pathophysiological Implications and Therapeutic Potential.
MedLine Citation:
PMID:  23143666     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Treatment options for adrenocortical carcinoma (ACC) are very limited. In other solid tumors, small vaccination trials targeting the anti-apoptotic molecule survivin suggested immunological and clinical benefit in selected patients. Therefore, we investigated whether survivin might be a suitable target for immunotherapy in ACC. Survivin mRNA and protein expression was assessed in adrenal tissue specimens [by real-time-PCR in 29 ACC, 24 adrenocortical adenomas (ACA) and 12 normal adrenal glands; by immunohistochemistry in 167 ACCs, 15 ACA, and 5 normal adrenal glands]. Expression was correlated with clinical outcome using Kaplan-Meier and Cox regression analyses. The anti-apoptotic role of survivin was investigated in the SW13 ACC cell line using survivin siRNA. The presence of spontaneous survivin specific T-cells in peripheral blood was assessed by FACS dextramere staining in 29 ACC patients in comparison to healthy controls. Survivin mRNA in ACC was significantly overexpressed when compared with ACA or normal adrenal glands. Immunohistochemistry confirmed survivin protein expression in 97% of the ACCs. In 83% of samples, staining was moderate or high and clinical outcome in this subgroup showed a trend towards poorer prognosis [hazard ratio for death 2.28 (95% CI 0.99-5.28); p=0.053]. Survivin knockdown in SW-13 cell significantly increased the rate of apoptosis. Finally, spontaneous survivin-reactive T cells were detectable in 3 of 29 ACC patients. In conclusion, our data suggest that survivin could play an important role in the anti-apoptotic mechanisms in ACC and provide first hints that targeting survivin might be an interesting new therapeutic approach in this rare disease.
Authors:
S Sbiera; M Kroiss; T Thamm; M Beyer; F Majidi; D Kuehner; M Wobser; J C Becker; P Adam; C Ronchi; B Allolio; M Fassnacht
Related Documents :
18021456 - Comparison of chicken 7sk and u6 rna polymerase iii promoters for short hairpin rna exp...
23917076 - Hepatitis b surface antigen (hbsag) inhibits mica and micb expression via induction of ...
24483336 - Lactobacillus gg restoration of the gliadin induced epithelial barrier disruption: the ...
24599886 - Pi3k/akt pathway restricts epithelial adhesion of dr+ escherichia coli by down-regulati...
23983646 - Gmnac5, a nac transcription factor, is a transient response regulator induced by abioti...
18829486 - Negative regulation of the osteoblast function in multiple myeloma through the represso...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-11-9
Journal Detail:
Title:  Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme     Volume:  -     ISSN:  1439-4286     ISO Abbreviation:  Horm. Metab. Res.     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-12     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0177722     Medline TA:  Horm Metab Res     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© Georg Thieme Verlag KG Stuttgart · New York.
Affiliation:
Department of Internal Medicine I, Endocrine and Diabetes Unit, University Hospital Würzburg, University of Würzburg, Würzburg, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Monoclonal anti-TNF antibodies can elevate hemoglobin level in patients with ankylosing spondylitis.
Next Document:  Impact of renal function on clopidogrel-induced antiplatelet effects in coronary artery disease pati...